3Arber S,Hunter JJ,Ross J Jr,et al.MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization,dilated cardiomyopathy,and heart failure.Cell,1997,88:393-403.
4Cohn RD,Durbeej M,Moore SA,et al.Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.J Clin Invest,2001,107:R1-R7.
5Azevedo VM,Albanesi Filho FM,Santos MA,et al.The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children.J Pediatr (Rio J),2005,81:368-372.
6Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.
8Codd MB,Sugrue DD,Gersh BJ,et al.Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy.A population-based study in Olmsted County,Minnesota,1975-1984.Circulation,1989,80:564-572.
9Dalakas MC,Park KY,Semino-Mora C,et al.Desmin myopathy,a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.N Engl J Med,2000,342:770-780.
10Muntoni F,Di Lenarda A,Porcu M,et al.Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.Heart,1997,78:608-612.
